Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1B | P49286 | 20/20 | 0.63 |
| ▸ | MTNR1A | P48039 | 19/20 | 0.63 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.63 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4692535 | 0.92 | MTNR1B (0.64) | MTNR1BMTNR1AABCB11SIGMAR1USP2 | |
| Ramelteon SCHEMBL29380213 | 0.78 | MTNR1A (1.00) | MTNR1BMTNR1AABCB11SIGMAR1USP2 | |
| (R)-Ramelteon SCHEMBL1566122 | 0.78 | MTNR1A (1.00) | MTNR1BMTNR1AABCB11SIGMAR1USP2 | |
| (R)-Ramelteon SCHEMBL29827337 | 0.78 | MTNR1A (1.00) | MTNR1BMTNR1AABCB11SIGMAR1USP2 | |
| (R)-Ramelteon SCHEMBL338730 | 0.78 | MTNR1A (1.00) | MTNR1BMTNR1AABCB11SIGMAR1USP2 | |
| Ramelteon SCHEMBL29237 | 0.78 | MTNR1A (1.00) | MTNR1BMTNR1AABCB11SIGMAR1USP2 | |
| SCHEMBL3053825 | 0.76 | MTNR1B (0.67) | MTNR1BMTNR1AABCB11SIGMAR1USP2 | |
| SCHEMBL3062045 | 0.76 | MTNR1B (0.67) | MTNR1BMTNR1AABCB11SIGMAR1USP2 | |
| SCHEMBL1567202 | 0.76 | MTNR1B (0.67) | MTNR1BMTNR1AABCB11SIGMAR1USP2 | |
| SCHEMBL4688084 | 0.76 | MTNR1A (0.38) | MTNR1BMTNR1AABCB11SIGMAR1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0885210-B2 | Tricylic compounds having binding affinity for melatonin receptors, their production and use | TAKEDA PHARMACEUTICAL (JP) | 2008-06-18 | — | — | EP | disclosed |
| EP-1550655-A1 | Bicyclic intermediates | Takeda Pharmaceutical Company Limited (JP) | 2005-07-06 | — | — | EP | disclosed |
| EP-0885210-B1 | Tricylic compounds having binding affinity for melatonin receptors, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2002-06-12 | — | — | EP | disclosed |
| EP-1199304-A1 | Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders | Takeda Chemical Industries, Ltd. (JP) | 2002-04-24 | — | — | EP | disclosed |
| US-6218429-B1 | TREATING MELATONIN RELATED DISORDERS (E.G. CIRCARDIAN RHYTHMS, SLEEP-AWAKE CYCLES, TIME ZONE CHANGES, SLEEP DISORDERS) | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-04-17 | — | — | US | disclosed |
| US-6034239-A | BINDIG TO MELATONIN RECEPTORS; SLEEP DISORDERS; GLANDULAR DISORDERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-03-07 | — | — | US | disclosed |
| EP-0885210-A1 | Tricylic compounds having binding affinity for melatonin receptors, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1998-12-23 | — | — | EP | disclosed |
| WO-1997032871-A1 | TRICYCLIC COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-09-12 | — | — | WO | disclosed |